Monday, August 15, 2022 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

WILMINGTON, Del. - Shareholders claim ISTA Pharmaceuticals is selling itself too cheaply to Bausch & Lomb, for $500 million or $9.10 a share, in Chancery Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading
Loading...